Cleared Traditional

K892900 - ACA VANCOMYCIN (VANC) METHOD

K892900 is the FDA 510(k) clearance for ACA VANCOMYCIN (VANC) METHOD by E.I. Dupont DE Nemours & Co., Inc.. It is a Class 2 Toxicology device (product code LEH) cleared through the Traditional 510(k) pathway after a 32-day FDA review.

K892900 · E.I. Dupont DE Nemours & Co., Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1989
Decision
32d
Days
Class 2
Risk

K892900 is an FDA 510(k) clearance for the ACA VANCOMYCIN (VANC) METHOD. Classified as Radioimmunoassay, Vancomycin (product code LEH), Class II - Special Controls.

Submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on May 22, 1989 after a review of 32 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3950 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all E.I. Dupont DE Nemours & Co., Inc. devices

Submission Details

510(k) Number K892900 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 1989
Decision Date May 22, 1989
Days to Decision 32 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
55d faster than avg
Panel avg: 87d · This submission: 32d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LEH Radioimmunoassay, Vancomycin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LEH Radioimmunoassay, Vancomycin

All 22
Devices cleared under the same product code (LEH) and FDA review panel - the closest regulatory comparables to K892900.
AXSYM VANCOMYCIN
K940595 · Abbott Laboratories · Jun 1994
OPUS(R) VANCOMYCIN
K924957 · Pb Diagnostic Systems, Inc. · Dec 1992
COBAS-FP REAGENTS FOR VANCOMYCIN
K901759 · Roche Diagnostic Systems, Inc. · May 1990
EMIT VANCOMYCIN ASSAY
K881040 · Syva Co. · Apr 1988
STRATUS VANCOMYCIN FLUOROMETRIC ENZYME IMMUNOASSAY
K874438 · Baxter Healthcare Corp · Jan 1988
VANCOMYCIN FLUORESCENT IMMUNOASSAY
K822308 · American Diagnostic Corp. · Aug 1982